Cross-genotype characterization of genetic diversity and molecular adaptation in hepatitis C virus envelope glycoprotein genes

Journal of General Virology

Volumn 88, Issue 2, 2007, Pages 458-469

  Brown, Richard J P ^a   Tarr, Alexander W ^a   McClure, C Patrick ^a   Juttla, Vicky S ^a   Tagiuri, Nader ^a   Irving, William L ^a   Ball, Jonathan K ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN E1; GLYCOPROTEIN E2; HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ARTICLE; CODON; CONTROLLED STUDY; DOWNSTREAM PROCESSING; EVOLUTIONARY HOMOLOGY; GENE LOCATION; GENE MUTATION; GENETIC DATABASE; GENETIC SELECTION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MOLECULAR GENETICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PURIFICATION; STATISTICAL ANALYSIS; UNINDEXED SEQUENCE; VIRUS ISOLATION;

AMINO ACID SEQUENCE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C, CHRONIC; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; SELECTION (GENETICS); SEQUENCE ANALYSIS, DNA; VARIATION (GENETICS); VIRAL ENVELOPE PROTEINS;

HEPATITIS C VIRUS;

EID: 33846813697     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.82357-0     Document Type: Article

References (75)

1. Alter, M. J., Margolis, H. S., Krawczynski, K., Judson, F. N., Mares, A., Alexander, W. J., Hu, P. Y., Miller, J. K., Gerber, M. A. & other authors (1992). The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med 327, 1899-1905.
2. Anisimova, M., Bielawski, J. P. & Yang, Z. (2001). Accuracy and power of the likelihood ratio test in detecting adaptive molecular evolution. Mol Biol Evol 8, 1585-1592.
3. Anisimove, M., Nielsen, R. & Yang, Z. (2003). Effect of recombination on the accuracy of the likelihood method for detecting positive selection at amino acid sites. Genetics 164, 1229-1236.
4. Bartosch, B., Verney, G., Dreux, M., Donot, P., Morice, Y., Penin, F., Pawlotsky, J. M., Lavillette, D. & Cosset, F. L. (2005). An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies. J Virol 79, 8217-8229.
5. Beaumont, T., Quakkelaar, E., van Nuenen, A., Pantophlet, R. & Schuitemaker, H. (2004). Increased sensitivity to CD4 binding site-directed neutralization following in vitro propagation on primary lymphocytes of a neutralization-resistant human immunodeficiency virus IIIB strain isolated from an accidentally infected laboratory worker. J Virol 78, 5651-5657.
6. Brown, R. J. P., Juttla, V. S., Tarr, A. W., Finnis, R., Irving, W. L., Hemsley, S., Flower, D. R., Borrow, P. & Ball, J. K. (2005). Evolutionary dynamics of hepatitis C virus envelope genes during chronic infection. J Gen Virol 86, 1931-1942.
7. Bukh, J., Miller, R. H. & Purcell, R. H. (1995). Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis 15, 41-63.
8. Callens, N., Ciczora, Y., Bartosch, B., Vu-Dac, N., Cosset, F. L., Pawlotsky, J. M., Penin, F. & Dubuisson, J. (2005). Basic residues in hypervariable region 1 of hepatitis c virus envelope glycoprotein E2 contribute to virus entry. J Virol 79, 15331-15341.
9. Choisy, M., Woelk, C. H., Guegan, J. F. & Robertson, D. L. (2004). Comparative study of adaptive molecular evolution in different human immunodeficiency virus groups and subtypes. J Virol 78, 1962-1970.
10. Clayton, R. F., Owsianka, A., Aitken, J., Graham, S., Bhella, D. & Patel, A. H. (2002). Analysis of antigenicity and topology of E2 glycoprotein present on recombinant hepatitis C virus-like particles. J Virol 76, 7672-7682.
11. Cocquerel, L., Quinn, E. R., Flint, M., Hadlock, K. G., Foung, S. K. & Levy, S. (2003). Recognition of native hepatitis C virus E1E2 heterodimers by a human monoclonal antibody. J Virol 77, 1604-1609.
12. Farci, P., Alter, H. J., Wong, D. C., Miller, R. H., Govindarajan, S., Engle, R., Shapiro, M. & Purcell, R. H. (1994). Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci U S A 91, 7792-7796.
13. Farci, P., Shimoda, A., Wong, D., Cabezon, T., De Gioannis, D., Strazzera, A., Shimizu, Y., Shapiro, M., Alter, H. J. & Purcell, R. H. (1996). Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc Natl Acad Sci U S A 93, 15394-15399.
14. Farci, P., Shimoda, A., Coiana, A., Diaz, G., Peddis, G., Melpolder, J. C., Strazzera, A., Chien, D. Y., Munoz, S. J. & other authors (2000). The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 288, 339-344.
15. Felsenstein, J. (1985). Confidence limits on phylogenies: an approach using the bootstrap. Evolution 39, 781-783.
16. Flint, M., Maidens, C., Loomis-Price, L. D., Shotton, C., Dubuisson, J., Monk, P., Higginbottom, A., Levy, S. & McKeating, J. A. (1999). Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81. J Virol 73, 6235-6244.
17. Fournillier, A., Wychowski, C., Boucreux, D., Baumert, T. F., Meunier, J. C., Jacobs, D., Muguet, S., Depla, E. & Inchauspe, G. (2001). Induction of hepatitis C virus E1 envelope protein-specific immune response can be enhanced by mutation of N-glycosylation sites. J Virol 75, 12088-12097.
18. Frasca, L., Del Porto, P., Tuosto, L., Marinari, B., Scotta, C., Carbonari, M., Nicosia, A. & Piccolella, E. (1999). Hypervariable region 1 variants act as TCR antagonists for hepatitis C virus-specific CD4 + T cells. J Immunol 163, 650-658.
19. Goffard, A. & Dubuisson, J. (2003). Glycosylation of hepatitis C virus envelope proteins. Biochimie 85, 295-301.
20. Goffard, A., Callens, N., Bartosch, B., Wychowski, C., Cosset, F. L., Montpellier, C. & Dubuisson, J. (2005). Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins. J Viral 79, 8400-8409.
21. Hadlock, K. G., Lanford, R. E., Perkins, S., Rowe, J., Yang, Q., Levy, S., Pileri, P., Abrignani, S. & Foung, S. K. (2000). Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes. J Virol 74, 10407-10416.
22. Heo, T. H., Chang, J. H., Lee, J. W., Foung, S. K., Dubuisson, J. & Kang, C. Y. (2004). Incomplete humoral immunity against hepatitis C virus is linked with distinct recognition of putative multiple receptors by E2 envelope glycoprotein. J Immunol 173, 446-455.
23. Hsu, M., Zhang, J., Flint, M., Logvinoff, C., Cheng-Mayer, C., Rice, C. M. & McKeating, J. A. (2003). Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc Natl Acad Sci U S A 100, 7271-7276.
24. IIIB GP120 peptide RP135. Biochemistry 36, 10846-10856.
25. Kiepiela, P., Leslie, A. J., Honeyborne, I., Ramduth, D., Thobakgale, C., Chetty, S., Rathnavalu, P., Moore, C., Pfafferott, K. J. & other authors (2004). Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 432, 769-775.
26. Kumar, S., Tamura, K & Nei, M. (2004). MEGA3: integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment. Brief Bioinform 5, 150-163.
27. Lanford, R. E., Guerra, B., Chavez, D., Bigger, C., Brasky, K. M., Wang, X. H., Ray, S. C. & Thomas, D. L. (2004). Cross-genotype immunity to hepatitis C virus. J Virol 78, 1575-1581.
28. Lavillette, D., Tarr, A. W., Voisset, C., Donot, P., Bartosch, B., Bain, C., Patel, A. H., Dubuisson, J., Ball, J. K. & Cosset, F. L. (2005). Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus. Hepatology 41, 265-274.
29. Li, Y., Luo, L., Rasool, N. & Kang, C. Y. (1993). Glycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 binding. J Virol 67, 584-588.
30. Lindenbach, B. D. & Rice, C. M. (2001). Flaviviridae: the viruses and their replication. In Fields Virology, 4th edn, pp. 991-1041. Edited by B. N. Fields, D. M. Knipe & P. M. Howley. New York: Lippincott Williams & Wilkins.
31. Lole, K. S., Bollinger, R. C., Paranjape, R. S., Gadkari, D., Kulkarni, S. S., Novak, N. G., Ingersoll, R., Sheppard, H. W. & Ray, S. C. (1999). Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 73, 152-160.
32. Majid, A., Jackson, P., Lawal, Z., Pearson, G. M. J., Parker, H., Alexander, G. J. M., Allain, J.-P. & Petrik, J. (1999). Ontogeny of hepatitis C virus (HCV) hypervariable region 1 (HVR1) heterogeneity and HVR1 antibody responses over a 3 year period in a patient infected with HCV type 2b. J Gen Virol 80, 317-325.
33. Martell, M., Esteban, J. I., Quer, J., Genesca, J., Weiner, A., Esteban, R., Guardia, J. & Gomez, J. (1992). Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol 66, 3225-3229.
34. Meunier, J.-C., Fournillier, A., Choukhi, A., Cahour, A., Cocquerel, L., Dubuisson, J. & Wychowski, C. (1999). Analysis of the glycosylation sites of hepatitis C virus (HCV) glycoprotein E1 and the influence of E1 glycans on the formation of the HCV glycoprotein complex. J Gen Virol 80, 887-896.
35. Moore, C. B., John, M., James, I. R., Christiansen, F. T., Witt, C. S. & Mallal, S. A. (2002). Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 296, 1439-1443.
36. Muller, R. (1996). The natural history of hepatitis C: clinical experiences. J Hepatol 24 (Suppl. 2), 52-54.
37. Owsianka, A., Clayton, R. F., Loomis-Price, L. D., McKeating, J. A. & Patel, A. H. (2001). Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimilarities between different forms of E2. J Gen Virol 82, 1877-1883.
38. Owsianka, A., Tarr, A. W., Juttla, V. S., Lavillette, D., Bartosch, B., Cosset, F. L., Ball, J. K. & Patel, A. H. (2005). Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein. J Virol 79, 11095-11104.
39. Penin, F., Combet, C., Germanidis, G., Frainais, P. O., Deleage, G. & Pawlotsky, J.-M. (2001). Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment. J Virol 75, 5703-5710.
40. Pinter, A., Honnen, W. J., He, Y., Gorny, M. K., Zolla-Pazner, S. & Kayman, S. C. (2004). The V1/V2 domain of gpl20 is a global regulator of the sensitivity of primary human immunodeficiency virus type I isolates to neutralization by antibodies commonly induced upon infection. J Virol 78, 5205-5215.
41. Posada, D. & Crandall, K. A. (1998). MODELTEST: testing the model of DNA substitution. Bioinformatics 14, 817-818.
42. Pugach, P., Kuhmann, S. E., Taylor, J., Marozsan, A. J., Snyder, A., Ketas, T., Wolinsky, S. M., Korber, B. T. & Moore, J. P. (2004). The prolonged culture of human immunodeficiency virus type 1 in primary lymphocytes increases its sensitivity to neutralization by soluble CD4. Virology 321, 8-22.
43. Pybus, O. G., Drummond, A. J., Nakano, T., Robertson, B. H. & Rambaut, A. (2003). The epidemiology and iatrogenic transmission of hepatitis C virus in Egypt: a Bayesian coalescent approach. Mol Biol Evol 20, 381-387.
44. Pybus, O. G., Cochrane, A., Holmes, E. C. & Simmonds, P. (2005). The hepatitis C virus epidemic among injecting drug users. Infect Genet Evol 5, 131-139.
45. Ray, S. C., Wang, Y. M., Laeyendecker, O., Ticehurst, J. R., Villano, S. A. & Thomas, D. L. (1999). Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region 1 as a decoy. J Virol 73, 2938-2946.
46. Robertson, D. L., Hahn, B. H. & Sharp, P. M. (1995). Recombination in AIDS viruses. J Mol Evol 40, 249-259.
47. Robertson, B., Myers, G., Howard, C., Brettin, T., Bukh, J., Gaschen, B., Gojobori, T., Maertens, G., Mizokami, M. & other authors (1998). Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy. Arch Virol 143, 2493-2503.
48. Roccasecca, R., Ansuini, H., Vitelli, A., Meola, A., Scarselli, E., Acali, S., Pezzanera, M., Bruni Ercole, B., McKeating, J. & other authors (2003). Binding of the hepatitis C virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2. J Viral 77, 1856-1867.
49. Saito, I., Miyamura, T., Ohbayashi, A., Harada, H., Katayama, T., Kikuchi, S., Watanabe, Y., Koi S., Onji, M. & other authors (1990). Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci U S A 87, 6547-6549.
50. Saltou, N. & Nei, M. (1987). The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4, 406-425.
51. Scarselli, E., Ansuini, H., Cerino, R., Roccasecca, R. M., Acali, S., Filocamo, G., Traboni, C., Nicosia, A., Cortese, R. & Vitelli, A. (2002). The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J 21, 5017-5025.
52. Schønning, K., Jansson, B., Olofsson, S. & Hansen, J.-E. S. (1996). Rapid selection for an N-linked oligosaccharide by monoclonal antibodies directed against the V3 loop of human immunodeficiency virus type 1. J Gen Virol 77, 753-758.
53. Sheridan, I., Pybus, O. G., Holmes, E. C. & Klenerman, P. (2004). High-resolution phylogenetic analysis of hepatitis C virus adaptation and its relationship to disease progression. J Virol 78, 3447-3454.
54. Shimizu, Y. K., Hijikata, M., Iwamoto, A., Alter, H. J., Purcell, R. H. & Yoshikura, H. (1994). Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J Virol 68, 1494-1500.
55. Shimizu, Y. K, Igarashi, H., Kiyohara, T., Cabezon, T., Farci, P., Purcell, R. H. & Yoshikura, H. (1996). A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures. Virology 223, 409-412.
56. Simmonds, P. (2001a). 2000 Fleming Lecture. The origin and evolution of hepatitis viruses in humans. J Gen Virol 82, 693-712.
57. Simmonds, P. (2001b). Reconstructing the origins of human hepatitis viruses. Philos Trans R Soc Lond B Biol Sci 356, 1013-1026.
58. Simmonds, P. (2004). Genetic diversity and evolution of hepatitis C virus - 15 years on. J Gen Virol 85, 3173-3188.
59. Simmonds, P., Bukh, J., Combet, C., Deleage, G., Enomoto, N., Feinstone, S., Halfon, P., Inchauspe, G., Kuiken, C. & other authors (2005). Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42, 962-973.
60. Sullivan, J, Swofford, D. L. & Naylor, G. J. P. (1999). The effect of taxon sampling on estimating rate heterogeneity parameters of maximum-likelihood models. Mol Biol Evol 16, 1347-1356.
61. Swofford, D. L. (2003). PAUP*: phylogenetic analysis using parsinomy (*and other methods).: Version 4. Sunderland, MA: Sinauer Associates.
62. Tamura, K. & Nei, M. (1993). Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. Mol Biol Evol 10, 512-526.
63. Tarr, A. W., Owsianka, A. M., Timms, J. M., McClure, C. P., Brown, R. J. P., Hickling, T. P., Pietschmann, T., Bartenschiager, R., Patel, A. H. & Ball, J. K. (2006). Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33. Hepatology 43, 592-601.
64. Triyatni, M., Vergalla, J., Davis, A. R., Hadlock, K. G., Foung, S. K. & Liang, T. J. (2002). Structural features of envelope proteins on hepatitis C virus-like particles as determined by anti-envelope monoclonal antibodies and CD81 binding. Virology 298, 124-132.
65. Wang, H. & Eckels, D. D. (1999). Mutations in immunodominant T cell epitopes derived from the nonstructural 3 protein of hepatitis C virus have the potential for generating escape variants that may have important consequences for T cell recognition. J Immunol 162, 4177-4183.
66. Wei, X., Decker, J. M., Wang, S., Hui, H., Kappes, J. C., Wu, X., Salazar-Gonzalez, J. F., Salazar, M. G., Kilby, J. M. & other authors (2003). Antibody neutralization and escape by HIV-1. Nature 422, 307-312.
67. WHO (1999). Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 6, 35-47.
68. Wu, Z., Kayman, S. C., Honnen, W., Revesz, K., Chen, H., Vijh-Warder, S., Tilley, S. A., McKeating, J., Shotton, C. & Pinter, A. (1995). Characterization of neutralization epitopes in the V2 region of human immunodeficiency virus type 1 gp120: role of glycosylation in the correct folding of the V1/V2 domain. J Virol 69, 2271-2278.
69. Yagnik, A. T., Lahm, A., Meola, A., Roccasecca, R. M., Ercole, B. B., Nicosia, A. & Tramontano, A. (2000). A model for the hepatitis C virus envelope glycoprotein E2. Proteins 40, 355-366.
70. Yang, Z. (1994a). Estimating the pattern of nucleotide substitution. J Mol Evol 39, 105-111.
71. Yang, Z. (1994b). Maximum likelihood phylogenetic estimation from DNA sequences with variable rates over sites: approximate methods. J Mol Evol 39, 306-314.
72. Yang, Z. (1997). PAML: a program package for phylogenetic analysis by maximum likelihood. Comput Appl Biosci 13, 555-556.
73. Yang, Z. & Bielawski, J. P. (2000). Statistical methods for detecting molecular adaptation. Trends Ecol Evol 15, 496-503.
74. Yang, Z., Nielsen, R., Goldman, N. & Pedersen, A. M. (2000). Codon-substitution models for heterogeneous selection pressure at amino acid sites. Genetics 155, 431-449.
75. Zhang, J., Randall, G., Higginbottom, A., Monk, P., Rice, C. M. & McKeating, J. A. (2004). CD81 is required for hepatitis C virus glycoprotein- mediated viral infection. J Virol 78, 1448-1455.